Zhang M, Wang H, He Y, Li W, Chen H, Zhang X
Stem Cell Res Ther. 2025; 16(1):124.
PMID: 40055828
PMC: 11887140.
DOI: 10.1186/s13287-025-04257-x.
Brust C, Swanson M, Bohn L
Biochem Soc Trans. 2023; 51(4):1533-1543.
PMID: 37646476
PMC: 10586759.
DOI: 10.1042/BST20221316.
Spatz P, Steinmuller S, Tutov A, Poeta E, Morilleau A, Carles A
J Med Chem. 2023; 66(9):6414-6435.
PMID: 37127287
PMC: 10184129.
DOI: 10.1021/acs.jmedchem.3c00541.
Gianquinto E, Sodano F, Rolando B, Kostrzewa M, Allara M, Mahmoud A
Molecules. 2022; 27(23).
PMID: 36500256
PMC: 9738591.
DOI: 10.3390/molecules27238152.
Sadybekov A, Sadybekov A, Liu Y, Iliopoulos-Tsoutsouvas C, Huang X, Pickett J
Nature. 2021; 601(7893):452-459.
PMID: 34912117
PMC: 9763054.
DOI: 10.1038/s41586-021-04220-9.
Cannabinoid receptor 2 deficiency enhances isoflurane-induced spatial cognitive impairment in adult mice by affecting neuroinflammation, neurogenesis and neuroplasticity.
Li C, Shi J, Sun J, Shi Y, Jia H
Exp Ther Med. 2021; 22(2):908.
PMID: 34257720
PMC: 8243338.
DOI: 10.3892/etm.2021.10340.
Molecular Targets of Cannabinoids Associated with Depression.
Paudel P, Ross S, Li X
Curr Med Chem. 2021; 29(11):1827-1850.
PMID: 34165403
PMC: 9007087.
DOI: 10.2174/0929867328666210623144658.
First In Class (,)-11-[2-(Arylmethylene)Hydrazono]-PBD Analogs As Selective CB2 Modulators Targeting Neurodegenerative Disorders.
Mingle D, Ospanov M, Radwan M, Ashpole N, Otsuka M, Ross S
Med Chem Res. 2021; 30(1):98-108.
PMID: 33776384
PMC: 7992105.
DOI: 10.1007/s00044-020-02640-2.
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Complex Structures.
Hua T, Li X, Wu L, Iliopoulos-Tsoutsouvas C, Wang Y, Wu M
Cell. 2020; 180(4):655-665.e18.
PMID: 32004463
PMC: 7898353.
DOI: 10.1016/j.cell.2020.01.008.
Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome.
Sharaf A, Mensching L, Keller C, Rading S, Scheffold M, Palkowitsch L
Front Mol Neurosci. 2019; 12:224.
PMID: 31616248
PMC: 6763791.
DOI: 10.3389/fnmol.2019.00224.
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.
Alapafuja S, Nikas S, Ho T, Tong F, Benchama O, Makriyannis A
Molecules. 2019; 24(19).
PMID: 31581433
PMC: 6804212.
DOI: 10.3390/molecules24193559.
Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X, Hua T, Vemuri K, Ho J, Wu Y, Wu L
Cell. 2019; 176(3):459-467.e13.
PMID: 30639103
PMC: 6713262.
DOI: 10.1016/j.cell.2018.12.011.
